Arsen Osipov is an Oncology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8700 Beverly Blvd
West Hollywood, CA 900481804
Telephone
310-423-6066Provider last certified this registry record 8 Jul 2020.
Clinical trials
- GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novocure Inc.Program year202528 payments
- ABBVIE INC.Program year20251 payment
- Ipsen Biopharmaceuticals, IncProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
60.5%Antidiarrheal microorganisms31.1%Creon92%Zenpep8%Part D<11 patientsSerotonin-3 Receptor Antagonist20%Ondansetron Hcl100%Part D≥44 patients+ 2 more classes in this area
Nervous system
27.7%Phenothiazine18.5%Prochlorperazine Maleate100%Part D≥43 patientsBenzodiazepine4.6%Lorazepam100%Part D<11 patients+ 2 more classes in this area
Blood & clotting
8.6%Factor Xa inhibitor5.9%Eliquis100%Part D≥11 patientsSalt solutions2.7%Sodium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2021–2025 per NIH RePORTER. The latest:
- Targeting the Stroma for Pancreatic Cancer Treatment
Cedars-Sinai Medical Center
FY2025$244,172K08CA259456 - Targeting the Stroma for Pancreatic Cancer Treatment
Cedars-Sinai Medical Center
FY2024$244,172K08CA259456 - Targeting the Stroma for Pancreatic Cancer Treatment
Cedars-Sinai Medical Center
FY2023$244,172K08CA259456
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”